Terns Pharmaceuticals, Inc. (TERN)
34.33
-1.64
(-4.56%)
USD |
NASDAQ |
Jan 23, 16:00
34.36
+0.04
(+0.10%)
After-Hours: 20:00
Terns Pharmaceuticals Total Assets (Annual): 363.93M for Dec. 31, 2024
Total Assets (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 840.55M |
| Altimmune, Inc. | 139.31M |
| Ligand Pharmaceuticals, Inc. | 941.77M |
| ADMA Biologics, Inc. | 498.38M |
| Viking Therapeutics, Inc. | 908.32M |